BR112023014408A2 - Composições e métodos para contorno corporal e procedimentos cirúrgicos - Google Patents

Composições e métodos para contorno corporal e procedimentos cirúrgicos

Info

Publication number
BR112023014408A2
BR112023014408A2 BR112023014408A BR112023014408A BR112023014408A2 BR 112023014408 A2 BR112023014408 A2 BR 112023014408A2 BR 112023014408 A BR112023014408 A BR 112023014408A BR 112023014408 A BR112023014408 A BR 112023014408A BR 112023014408 A2 BR112023014408 A2 BR 112023014408A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
surgical procedures
body contouring
contouring
Prior art date
Application number
BR112023014408A
Other languages
English (en)
Inventor
David Widgerow Alan
A Garruto John
Original Assignee
Alastin Skincare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alastin Skincare Inc filed Critical Alastin Skincare Inc
Publication of BR112023014408A2 publication Critical patent/BR112023014408A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1741—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals alpha-Glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

composições e métodos para contorno corporal e procedimentos cirúrgicos. são divulgadas neste documento composições tópicas e métodos de uso para aprimorar ou melhorar os efeitos associados ao contorno corporal ou procedimentos cirúrgicos. as composições como aqui descritas compreendem um ou mais peptídeos.
BR112023014408A 2021-01-19 2022-01-18 Composições e métodos para contorno corporal e procedimentos cirúrgicos BR112023014408A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163139088P 2021-01-19 2021-01-19
US202163225857P 2021-07-26 2021-07-26
US202163289042P 2021-12-13 2021-12-13
PCT/US2022/012796 WO2022159394A1 (en) 2021-01-19 2022-01-18 Compositions and methods for body contouring and surgical procedures

Publications (1)

Publication Number Publication Date
BR112023014408A2 true BR112023014408A2 (pt) 2023-10-03

Family

ID=82549639

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023014408A BR112023014408A2 (pt) 2021-01-19 2022-01-18 Composições e métodos para contorno corporal e procedimentos cirúrgicos

Country Status (8)

Country Link
US (1) US20240000882A1 (pt)
EP (1) EP4281037A1 (pt)
JP (1) JP2024503721A (pt)
AU (1) AU2022210290A1 (pt)
BR (1) BR112023014408A2 (pt)
CA (1) CA3208810A1 (pt)
MX (1) MX2023008501A (pt)
WO (1) WO2022159394A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510732B2 (en) * 2005-02-16 2009-03-31 Cambridge Scientific Pty Ltd Analgesic and anti-inflammatory composition
KR101810160B1 (ko) * 2017-06-30 2018-01-25 주식회사 셀리제코스메틱 생리활성물질이 봉입된 에토좀 제조 방법, 에토좀 조성물 및 에토좀 조성물을 포함하는 화장료 조성물
CA3071645A1 (en) * 2017-08-03 2019-02-07 ALASTIN Skincare, Inc. Compositions and methods for ameliorating skin laxity and body contour
US11103455B2 (en) * 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
BR112021022242A2 (pt) * 2019-05-08 2022-01-18 Alastin Skincare Inc Composições e métodos para melhorar hematoma e para rejuvenescimento da pele

Also Published As

Publication number Publication date
JP2024503721A (ja) 2024-01-26
US20240000882A1 (en) 2024-01-04
WO2022159394A1 (en) 2022-07-28
AU2022210290A1 (en) 2023-09-07
EP4281037A1 (en) 2023-11-29
CA3208810A1 (en) 2022-07-28
MX2023008501A (es) 2023-10-05

Similar Documents

Publication Publication Date Title
BR112012031727A2 (pt) conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença.
BR112022021445A2 (pt) Métodos e composições para tratar condições inflamatórias associadas com doença infecciosa
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
BR112022022401A2 (pt) Terapia de combinação tripla para aumentar o extermínio de células cancerígenas em cânceres com baixa imunogenicidade
BR112022001415A2 (pt) Agentes interleucina-2 e os usos dos mesmos
BR112016022318A2 (pt) método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo
BR112022003335A2 (pt) Conjugados de il-2 e métodos de uso para tratar doenças autoimunes
BR112022019020A2 (pt) Proteínas de fusão de il12 mascaradas e métodos de uso das mesmas
BR112022001341A2 (pt) Inibidores de enzima
AR120223A1 (es) Proteínas que unen nkg2d, cd16 y flt3
CL2021000129A1 (es) Apirasas solubilizadas, métodos y usos
BR112022004397A2 (pt) Composições para tratamento bucal que compreendem beta ácidos de lúpulo e aminoácidos
BR112018067923A2 (pt) métodos de tratamento de cânceres usando antagonistas de ligação de eixo pd-1 e anticorpos anti-gpc3
BR112018068886A2 (pt) conjugado de finasterida com peptídeo
BR112023014408A2 (pt) Composições e métodos para contorno corporal e procedimentos cirúrgicos
BR112018000655A2 (pt) peptídeos promotores do crescimento e seu uso
BR112022020809A2 (pt) Composições e métodos para entrega terapêutica direcionada ao osso
BR112018069035A2 (pt) composições e métodos para estabilização de alfavírus com formulações melhoradas
BR112021015638A2 (pt) Métodos, composições contendo bactéria produtora de bacileno ou preparações das mesmas
EA202191403A1 (ru) Композиция с высокой концентрацией белка
BR112018006572A2 (pt) terapia de combinação racional para o tratamento de câncer
EA202090437A1 (ru) Синергетическая композиция в качестве промотора аутофагии
BR112023003265A2 (pt) Inibidores de secreção de proteínas
EA201800240A1 (ru) Гемостатическая композиция
BR112021022900A2 (pt) Expressão de proteínas modificadas em peroxissoma